SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-013832
Filing Date
2023-04-27
Accepted
2023-04-27 16:30:46
Documents
7
Period of Report
2023-04-27

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 380346
2 formdef14a_001.jpg GRAPHIC 3364
3 formdef14a_002.jpg GRAPHIC 52200
4 proxy_001.jpg GRAPHIC 283613
5 proxy_002.jpg GRAPHIC 209570
6 proxy_003.jpg GRAPHIC 295784
7 proxy_004.jpg GRAPHIC 180155
  Complete submission text file 0001493152-23-013832.txt   1792557
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38738 | Film No.: 23857583
SIC: 2834 Pharmaceutical Preparations